ARCHIVES

Glaxo, Mass General Begin Phase III Trial Of Tykerb

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

AGS-003 Increased Survival In Combination with Sunitinib

February 24, 2012

SAIC Frederick Offers Use Of Drug Facility

August 4, 1995

In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished

November 29, 1996

Obituary: Gregory Foltz, Swedish Medical Center Neurosurgeon

July 12, 2013

First CCOP 3 Returns In; Payline Not Yet Determined; Goes to NCAB On Jan. 30

January 26, 1990

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007